Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-011664
Filing Date
2018-05-07
Accepted
2018-05-07 17:47:10
Documents
2
Period of Report
2018-04-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7458
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3287
  Complete submission text file 0000899243-18-011664.txt   12411
Mailing Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932
Business Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Issuer) CIK: 0000315545 (see all company filings)

EIN.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2220 SOUTHERLAND AVE KNOXVILLE TN 37919
Business Address
Pershing Edward (Reporting) CIK: 0001689739 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36457 | Film No.: 18812377